Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue

The defining feature of Parkinson disease (PD) and Lewy body dementia (LBD) is the accumulation of alpha-synuclein (Asyn) fibrils in Lewy bodies and Lewy neurites. We developed and validated a novel method to amplify Asyn fibrils extracted from LBD postmortem tissue samples and used solid state nucl...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Borcik, Collin, Dhavale, Dhruva, Barclay, Alexander, Basore, Katherine, Berthold, Deborah, Gordon, Isabelle, Liu, Jialu, Milchberg, Moses, O’Shea, Jennifer, Rau, Michael, Smith, Zachary, Sen, Soumyo, Summers, Brock, Smith, John, Warmuth, Owen, Perrin, Rick, Perlmutter, Joel, Chen, Qian, Fitzpatrick, James, Schwieters, Charles, Tajkhorshid, Emad, Rienstra, Chad, Kotzbauer, Paul
Format: Dataset
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The defining feature of Parkinson disease (PD) and Lewy body dementia (LBD) is the accumulation of alpha-synuclein (Asyn) fibrils in Lewy bodies and Lewy neurites. We developed and validated a novel method to amplify Asyn fibrils extracted from LBD postmortem tissue samples and used solid state nuclear magnetic resonance (SSNMR) studies to determine atomic resolution structure. Amplified LBD Asyn fibrils comprise a mixture of single protofilament and two protofilament fibrils with very low twist. The protofilament fold is highly similar to the fold determined by a recent cryo-electron microscopy study for a minority population of twisted single protofilament fibrils extracted from LBD tissue. These results expand the structural characterization of LBD Asyn fibrils and enable new approaches for studies of disease mechanisms, imaging agents and therapeutics targeting Asyn.
DOI:10.5061/dryad.tx95x6b4z